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Dietary cholesterol, female gender and n-3 fatty
acid deficiency are more important factors in the
development of non-alcoholic fatty liver disease
than the saturation index of the fat
Tine M Comhair1,3,5†, Sonia C Garcia Caraballo1,3†, Cornelis HC Dejong2,3, Wouter H Lamers1,3,4, S Eleonore Köhler1,3*
Abstract
Background: The central feature of NAFLD is a disturbed fatty-acid metabolism with hepatic lipid accumulation.
However, the factors that determine the severity of NAFLD, including the role of nutrition, gender, and plasma lipid
levels, remain to be determined.
Methods: High-fat diets (42 en% fat), containing 0.2% cholesterol, were fed to male and female wild-type and
hyperlipidemic APOE2ki C57BL/6J mice for three weeks. The fats were, in order of decreasing saturation,
fractionated palm fat (fPF; ~95%), cocoa butter (CB; ~60%), olive oil (OO; ~15%), sunflower oil (SO; ~12%), and
high-oleic-acid sunflower oil (hoSO; ~7%). Plasma and liver triglycerides (concentration and composition), liver
inflammation (Ccl2, Cd68, Tnf-a mRNA), and infiltration of macrophages (Cd68, Cd11b immunohistochemistry) and
neutrophils (Mpo) were quantified.
Results: Addition of cholesterol to a low-fat diet decreased plasma HDL and increased (V)LDL levels in APOE2ki
mice. Plasma cholesterol levels in female, but not male APOE2ki mice correlated significantly with inflammation.
Kupffer cells of inflamed livers were swollen. Wild-type mice refused the highly saturated fPF diet. The high-fat CB,
OO, and SO diets induced hyperglycemia and a 2-fold increase in hepatic fat content in male, but not female wild-
type mice (in females, hepatic fat content was similar to that in males fed a high-fat diet). All high-fat diets
induced macrovesicular setatosis. APOE2ki mice were protected against high-fat diet-induced steatosis and
hyperglycemia, except when fed a hoSO diet. This diet caused a 5-fold increase in liver triglyceride and mead-acid
content, and an increased expression of lipogenic genes, suggesting a deficiency in poly-unsaturated fatty acids.
Irrespective of the composition of the high-fat diet, oleic acid was the main triglyceride component of liver fat in
wild-type and APOE2ki mouse livers. Liver inflammation was dependent on genotype (APOE2ki > wild type),
gender (female > male), and cholesterol content (high > low) of the diet, but not on dietary fat composition.
Conclusions: Dietary cholesterol plays a determining, independent role in inflammation, especially in female mice.
The fatty-acid saturation of the diet hardly affected hepatic steatosis or inflammation.
Background
Non-alcoholic fatty liver disease (NAFLD) refers to the
non-physiological accumulation of fat in the liver. The
increased prevalence of NAFLD is a concomitant effect
of the increased incidence of obesity and a feature of
the metabolic syndrome [1]. The central feature of
NAFLD is a disturbed fatty-acid metabolism with hepa-
tic lipid accumulation. Lipid accumulation alone is
benign, but may sensitize the liver to hepatic injury (2-
hit hypothesis) [2]. Alternatively, harmful side products
(e.g. (lyso-) phosphatidic acid, lysophosphatidylcholine,
diacylglycerols, and ceramides) of enhanced fatty-acid
metabolism may be responsible for liver damage (lipo-
toxicity hypothesis) [3]. However, the cause(s) and
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circumstances that determine the severity of NAFLD,
including the role of nutrition, gender, and plasma lipid
levels, remain to be determined.
The limited progress in clarifying the causes of NASH
may at least partly be due to the diversity in the
reported effects of different dietary fats in various mod-
els. Saturated fats, especially palmitic acid, may facilitate
the progression of NAFLD to NASH by inducing endo-
plasmic reticulum (ER) stress and/or the synthesis of
ceramides [4]. Monounsaturated fats (MUFA), such as
olive oil, were, on the other hand, reported to be more
effective in decreasing steatosis in the methionine-cho-
line deficient model than fish oil or butter fat [5]. Fish
oil, in turn, appears to have more reproducible effects
than polyunsaturated plant oils [6,7]. In fact, plant
PUFAs appear not to be more beneficial in rodents with
respect to steatosis than saturated fats [4,5,8]. Most of
these studies were carried out in (Wistar) rats [6,9], but
such data are not yet available for a mouse strain that is
prone to become obese on a high-fat diet, such as WT
mice, nor in a model for steatohepatitis.
Gender has been described as an important factor in
the outcome of various liver diseases including hepatic
steatosis and inflammation [10], yet most studies only
employed male mice (e.g. none of the above mentioned
studies showed female data).
Hyperlipidemic APOE2ki mice are more prone to liver
inflammation and reportedly a promising model for the
progression of NAFLD to NASH [11,12]. The replace-
ment of the mouse Apoe gene with the human APOE2
allele in APOE2ki mice decreases the hepatic uptake of
(very) low-density lipoproteins and, thus, causes mixed
hyperlipidemia [13]. In these studies female mice were
more prone to inflammation, but it remains unknown if
modulation of the fat source may influence the outcome.
In this study, we show that dietary cholesterol plays a
determining, independent role in inflammation and that
liver health is especially affected in female mice by diet-
ary cholesterol. The fatty-acid saturation, on the other
hand, plays only an insignificant role in terms of hepatic
steatosis or inflammation.
Methods
Animals and treatments
C57BL/6J and Apoetm(APOE2) mice on the C57BL/6J
background were used. Apoetm(APOE2) mice, in which the
mouse Apoe gene is replaced by the human APOE2
gene [13], were kindly provided by P. van Gorp (Dept.
of Molecular Genetics, Maastricht University). C57BL/6J
and Apoetm(APOE2) mice are designated as WT and
APOE2ki, respectively, in text and figures. Both male
and female mice were studied. Two mice per cage were
kept in a temperature-controlled facility with fixed 12 h
light-dark cycles and free access to food and water.
Twice weekly, food intake and body weight were mea-
sured. After three weeks on the specified diet, mice
were sacrificed in the morning to avoid chronobiological
variation. The study was approved by the Committee for
Animal Care and Use of Maastricht University.
Mice were anesthetized by intraperitoneal injection of
9 mL/kg body weight of a mixture of midazolam (Dor-
micum®, Roche, Almere, Netherlands), fluanisone/fenta-
nyl citrate (Hypnorm®, VetaPharma, Leeds, UK), and
sterile water (1:1:2 (v/v)). Fifteen minutes after injection,
the mice were laparotomized to sample caval blood and
tissues. The liver and epididymal/parametrial fat were
weighed and snap-frozen for further analysis.
Diets
Two semi-synthetic low-fat diets (without and with sup-
plemented cholesterol; 11 en% protein, 81 en% carbohy-
drates, and 8 en% fat; 3.8 kcal/g) and five semi-synthetic,
high-fat diets with the same macro-nutrient composition
(11 en% protein, 48 en% carbohydrates, and 42 en% fat
including 0.2% (w/w) cholesterol; 4.6 kcal/g) and were
purchased from Research Diets Inc. (New Brunswick, NJ,
USA) and stored at 4ºC until use. High-fat diets differed
only in the source of fat and saturation of the fatty acids
(Figure 1 and additional file 1, table S1: Composition of
control and high-fat diets). In addition to the commonly
used cocoa butter, olive and sunflower oil, we included a
sunflower-oil diet (hoSO) with a very high oleic-acid con-
tent (~88%; Trisun®) and a highly saturated, fractionated
fPF CB OO SO hoSO OO
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Figure 1 Macronutrient (en%; panel A) and fatty-acid
composition (panel B) of the diets.
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palm-fat (fPF) diet with high palmitic acid content
(~ 56%; Optifat®).
Oil-red O quantification
Fat accumulation in the livers was visualized using Oil-
red O staining. Five random high-power photographs
(20 × objective) were recorded per liver and quantified
with the Qwin™ image analysis software (Leica Micro-
systems B.V., Wetzlar, Germany). The total Oil-red O-
positive surface (= volume) fraction and the fat droplet
size distribution were determined. Macrosteatosis was
defined as the volume percentage of fat globules with a
radius larger than ~2 μm.
Immunohistochemistry
Formalin-fixed sections were used to stain for the pre-
sence of myeloperoxidase (Mpo, a neutrophil marker).
After deparaffinization, sections were blocked with 0.6%
H2O2 in 80% methanol for 15 min. Non-specific binding
was blocked with 10% normal goat serum (NGS) in
Teng-T buffer (100 mM Tris-HCl, pH 8.0, 50 mM
EDTA, 1.5 mM NaCl, 2.5% gelatin, 0.5% Tween) for 30
min. Liver sections were incubated with primary anti-
body (rabbit-a-Mpo (Dako, Glostrup, Denmark), 1:1500
in 10% NGS/TengT-buffer) for 1 h at room tempera-
ture, followed by secondary antibody (biotinylated goat-
anti-rabbit, Dako) and ABC-HRP-complex for 30 min.
Antibody binding was visualized with 3,3-diaminobenzi-
dine (DAB; Sigma-Aldrich, MO, USA).
Frozen liver sections (7 μm) were stained for the pre-
sence of Cd68-positive cells (residential phagocytic
macrophages) and Cd11b-positive cells (infiltrated/acti-
vated macrophages). Sections were air-dried and fixed in
100% ice-cold acetone. Nonspecific binding was blocked
by pre-incubation in PBS containing 4% (v/v) fetal calf
serum (FCS) and 240 μL/mL avidin D solution (Vector
Laboratories, Burlingame, CA, USA). Cd68 (Rat-anti-
Cd68, Hycult Biotechnology, Uden, The Netherlands)
and Cd11b (Rat-anti-Cd11b, R&D Systems, McKinley,
MN, USA) antibodies were dissolved in 4% (v/v) FCS/
PBS with 240 μL/mL biotin D solution (Vector Labora-
tories) and incubated on the section for 1 h. The second-
ary antibody was preincubated with 4% (v/v) FCS/2%
normal mouse serum (NMS)/PBS for at least 10 minutes
to reduce nonspecific binding. Antibody binding was
visualized with 3-amino-9-ethylcarbazole (AEC; Sigma-
Aldrich). Sections were scored blinded and independently
by three persons and scores are depicted as median and
quartile values per group (definition of scoring grades,
see additional file 2, table S2: Cd11b-scoring criteria).
Plasma analysis
Whole-blood glucose was measured with a glucose
meter (Ascencia Contour, Bayer, Leverkusen, Germany).
Heparinized plasma was prepared from remaining
blood, snap-frozen in liquid nitrogen and stored at
-80°C. Plasma triglycerides were determined using the
Triglyceride/Glycerol Blanked kit (Roche Diagnostics,
Almere, Netherlands) and non-esterified fatty acids
(NEFA) with the NEFA-C kit (WAKO Chemicals, Neus,
Germany). Total plasma cholesterol levels were deter-
mined with an enzymatic assay (bioMérieux, Marcy
l’Etoile, France). Lipoprotein profiles of pooled plasma
samples were determined using the AKTA chromatogra-
phy system equipped with a Superose 6PC 3.2/30 col-
umn (Amersham Biosciences, Diegem, Belgium) [11].
Liver lipid analysis
Hepatic triglyceride content was analyzed as described
previously [11]. Briefly, ~50 mg of frozen liver tissue
was homogenized with an Ultraturrax and sonicated for
30 sec in 1.0 mL SET buffer (sucrose 250 mM, EDTA
2 mM and Tris-HCl 10 mM, pH 7.4). Complete cell
destruction was achieved by one freeze-thaw cycle and
two 15-sec cycles of sonication (amplitude: 10 μm).
Liver triglycerides were analyzed using the same kit as
described for plasma triglyceride analysis. Protein con-
tent was measured with the bicinchoninic acid (BCA)
method (Pierce, Rockford, IL, USA). To determine the
fatty-acid composition of the liver, the samples of
every group were pooled, and fat was extracted and
separated by thin layer chromatography (TLC) [14].
The triglyceride fraction was further analyzed by gas
chromatography [15].
Quantitative PCR
Total RNA was isolated from approx. 50 mg tissue using
the TRI REAGENT™ (Sigma-Aldrich) and further puri-
fied by 2 M LiCl precipitation. cDNA synthesis was per-
formed on denatured RNA (5 min at 65°C, then
quenched on ice) with iScript™ cDNA-synthesis kit
(Bio-Rad Laboratories, Veenendaal, The Netherlands).
Real-time PCR was performed in the iQ5 thermal cycler
(Bio-Rad Laboratories) and the corresponding PCR-
reagents (iQ SYBR Green Supermix™), using specific
primers for chemokine (C-C motif) ligand 2 (Ccl2),
tumor necrosis factor a (Tnf-a) and macrosialin (Cd68)
(for primer sequences, see additional file 3, table S3: Pri-
mer sequences for quantitative PCR). 18S ribosomal
RNA was used as a reference. Relative mRNA levels
were quantified with the LinReg software [16], which
uses linear regression of the time-dependent increase in
Log(fluorescence).
Statistical methods
Data are shown as means ± SEM. Comparisons were
computed with SPSS version 15 (SPSS Inc., IL USA),
using ANOVA and post-hoc analysis. For data with
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equal variance, the Hochberg’s GT2 test was used,
whereas for the remaining cases, Games-Howell was
applied. P < 0.05 was considered significant.
Results
Animal characteristics
Biometric details (age and body weight at the start of the
experiment, and glucose, fat pad, liver weight at the end of
the experiment) of the mice in this study are given in addi-
tional file 4, table S4: Biometric details of experimental
mice. Male WT mice on the cocoa-butter diet consumed
more food (P < 0.02), but mice on all other diets had simi-
lar energy intakes per day during the second and third
week (additional file 5, figure S1A: Energy intake and
change in body weight of mice fed the respective high-fat
diets). Furthermore, WT mice refused the highly saturated
fPF diet. To test whether another background would
respond differently, mice of the obesity-resistant FVB strain
[17] were fed the fPF diet. Food intake of FVB mice on the
fPF diet was normal and comparable to food intake of WT
mice on the other diets. No significant differences in weight
gain were seen between or within groups of mice subjected
to a high-fat diet (additional file 5, figure S1B: Energy intake
and change in body weight of mice fed the respective high-
fat diets). An effect of gender on weight changes was only
seen in the WT mice (P = 0.03). Male WT mice on high-
fat diets show significantly increased plasma glucose con-
centrations compared to the low-fat diet (P < 0.001) and
compared to female WT mice on high-fat diets (P = 0.001;
additional file 4, table S4: Biometric details of experimental
mice). In APOE2ki mice no significant differences were
detectable between high- and low-fat diets or genders.
Effect of cholesterol supplementation
The addition of 0.2% cholesterol to a low-fat diet did not
affect plasma cholesterol levels in WT mice, but
increased plasma triglycerides ~2-fold (P < 0.001) and, in
males only, plasma NEFA levels decreased to ~75% (Fig-
ure 2A-C). Dietary cholesterol modulated the plasma
lipid profile in APOE2ki mice significantly (Figure 2A-D).
Plasma cholesterol increased ~2.5-fold when cholesterol
was added to the diet (Figure 2A), whereas plasma trigly-
cerides (Figure 2B) and non-esterified fatty acids
(Figure 2C) decreased to ~50% (P < 0.001). A consistent
gender difference was only found for plasma triglycerides
(P < 0.001). FPLC analysis revealed that the addition of
cholesterol to the diet increased VLDL and LDL concen-
trations, and decreased HDL concentration in APOE2ki
mice (Figure 2D). The cholesterol-containing low-fat diet
increased liver TG ~1.4-fold in female WT mice (P <
0.001; Figure 2E). Male WT and APOE2ki mice, however,
showed no differences in liver triglyceride concentrations.
As shown in Figure 2F, APOE2ki mice showed more
activated macrophage infiltration in the liver than WT
mice on a cholesterol-free low-fat diet, which was yet
further increased upon cholesterol addition (P < 0.001).
RT-PCR of Cd68, Tnf-a and Ccl2 showed that especially
female mice responded with an increased expression of
these genes when cholesterol was present in the diet
(Figure 2G-I; P = 0.003). Since Western-style diets
usually contain a liberal amount of cholesterol, we con-
tinued our study with dietary fats with a different degree
of saturation in the presence of 0.2% cholesterol.
Plasma parameters are not modulated by the degree of
saturation of the dietary fat
The plasma cholesterol profile differed substantially
between WT and APOE2ki mice (Figure 3A). The con-
centration of HDL did not differ between the different
diets and genotypes (Figure 3D, E). In WT mice, neither
LDL nor VLDL were found in plasma (Figure 3D).
Plasma lipid profiles of APOE2ki mice on either the CB-,
OO- or SO-diet were similar, but revealed lower VLDL
concentrations than on both the hoSO- and the low-fat
control diet (Figure 3E). No gender differences were
found (data not shown).
WT mice showed no difference in total plasma choles-
terol levels between the low- and high-fat diets, and
between the different high-fat diets themselves (Figure
3A). On average, in APOE2ki mice, plasma cholesterol
in mice fed the CB, OO or SO diets was ~60% of that
on the low-fat diet (P = 0.001). Furthermore, APOE2ki
mice had 5-10-fold higher plasma triglyceride and 2-fold
higher non-esterified fatty acid levels than WT mice (P
< 0.001 and P < 0.01, respectively; Figure 3B, C).
APOE2ki mice on the low-fat diet show significantly
reduced plasma TG and non-esterified fatty acids when
compared to the high-fat diets (P < 0.001). Female
APOE2ki mice had ~2-fold lower plasma triglyceride
concentrations than male APOE2ki mice (P < 0.001).
No significant effects were found between the different
high-fat diets in WT or APOE2ki mice. Thus, the main
differences in plasma lipid profiles were caused by the
genotype and gender rather than the type of fat.
Saturation of dietary fat influences neither the degree of
steatosis nor the distribution of fat in the liver
We investigated lipid accumulation in the liver and its
distribution in macro- and microvesicular fat globules
(Figure 4). In WT mice, the feeding of any of the high-fat
diets resulted in higher fat content in liver compared to
the low-fat diet (male: ~2-fold, P < 0.05; female: ~1.2-fold,
P = n.s.; Figure 4A). APOE2ki mice showed no extra fat
accumulation in the liver when fed a CB, OO or SO high-
fat diet. Consequently, WT mice had significantly more fat
in their livers than APOE2ki mice when fed a high-fat diet
(P < 0.007). The quantification of total liver fat with Oil-
red O confirmed these results. A direct comparison
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showed that the biochemical and histochemical assays of
fat accumulation in the liver correlated well (Figure 4B).
Quantitative morphological analysis revealed a continuous
size distribution of the fat vesicles, regardless of the diet
consumed. The size distribution of these vesicles changed
towards a larger diameter in animals on a high-fat diet
(Figure 4C), demonstrating that diet-induced steatosis is
macrovesicular.
The hoSO diet differed strikingly in its effects from the
other fats, in particular in APOE2ki mice. These mice
showed a remarkable ~4-fold increase in liver fat relative
to the other high-fat diets (P < 0.001; Figure 4A).
Furthermore, mead acid (Figure 4D) and mRNA levels of
fatty acid synthase (Fasn) and sterol regulatory element-
binding transcription factor 1 (Srebf1), both markers of
increased lipogenesis (Figure 4E), were significantly upre-
gulated compared to APOE2ki mice fed a high-fat OO
diet (P = 0.035 and P = 0.008, respectively). Stearoyl-CoA
desaturase 1 (Scd1) mRNA was unchanged (Figure 4E).
Saturation of dietary fat has only a minor effect on liver
fat composition
The composition of liver fat of mice fed fats with differ-
ent degrees of saturation showed a remarkable similarity
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(Figure 4F, additional file 6, table S5: Triglyceride fatty
acid composition (mol%)). For all diets, oleic acid was
the main fatty acid in the liver (~70%). Only the sun-
flower-oil diet was associated with a slightly, but consis-
tently higher C18:2 content. As depicted in Figure 4F,
the composition of the diet was therefore only partially
reflected in the fat composition of the liver. Fatty-acid
composition of SO-fed mice stands out with an
increased very long chain fatty acids (>C22) of both the
n-3 (22:5n-3, 22:6n-3; P < 0.001) and n-6 (20:4n-6,
22:4n-6; P < 0.001) series. On the other hand, n-3-to-n-
6 ratio was significantly decreased in SO-fed animals
due to the higher content of elongated n-6 PUFAs and
lowering the dietary 18:3n-3 fatty acid compared with
the other high fat diets. The liver of hoSO-fed mice,
finally, contained more mead acid (P < 0.05) and
showed a consistent trend for less elongation products
(20:3n-6, 20:4n-6, 22:4n-6 and 22:5n-6; P < 0.07) than
the liver of OO-fed mice (additional file 6, table S5: Tri-
glyceride fatty acid composition (mol%)).
Saturation of dietary fat does not influence liver
inflammation
Cd68-positive (resident) macrophages were abundantly
present in the livers of all mice, with no difference
between genotypes, gender, or diets. APOE2ki mice
showed swollen Cd68-positive cells both on the high-fat
and the low-fat diet containing cholesterol, but not on the
low-fat diet without cholesterol (inserts of Figure 5A and
5B). Activated (Cd11b-positive) macrophages were, on the
other hand, rarely present in the liver of WT mice (Figure
5C), but abundant in that of APOE2ki mice (P < 0.001;
Figure 5D). Since no diet-dependent effects were detected,
we conclude that macrophage activation was determined
primarily by genotype (P = 0.001) and, to a lesser extent,
by gender (Figure 5G). Mpo-positive cells (Figure 5E, F)
were seen almost exclusively in livers with the highest
grade of Cd11b-positive cells (24% of all samples with
score 3 of APOE2ki mice). The higher inflammatory status
of the APOE2ki mice was confirmed by real-time PCR.
Cd68, Tnf-a, and Ccl2 mRNA contents were 2-6-fold
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and APOE2ki mice fed the respective diets. FPLC analysis of plasma lipoproteins of male WT (D) and APOE2ki (E) mice. The plasma lipoprotein
profiles of female mice were similar to those of male mice. Values are shown as means ± SEM of 6-10 mice per group. Different letters indicate
a significant difference (P < 0.05) between these groups. GT: genotype; n.s.: non significant.
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Figure 4 The concentration of triglycerides in liver. Panel A shows the triglyceride concentration measured enzymatically. Panel C indicates
the percentage of fat present as >2 μm (macrovesicular) globules determined morphometrically in Oil-red O-stained sections. The correlation of
the biochemical assay (Panel A) and the histochemical assay (Panel C) is shown in panel B (P < 0.001). Assuming ~150 mg protein per gram liver
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and Scd1 mRNA expression in the liver of hoSO and olive oil-fed APOE2ki mice. Panel F compares the composition of liver fat as determined by
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higher in APOE2ki than in WT mouse livers (P < 0.001;
Figure 6A, B, and 6C, respectively). In WT mice, we did
not find a consistent induction of Cd68, Tnf-a, or Ccl2
mRNA expression by any of the diets.
There were subtle, but consistent gender differences in
inflammatory response. Female mice showed a signifi-
cantly higher density of Cd11b-positive cells and a higher
expression of inflammatory markers. Interestingly, liver
inflammation remained high in female mice on the low-fat
control diet, whereas the number of Cd11b-positive cells
and inflammatory gene expression decreased in male
mice. OO-fed female mice showed a consistently higher
inflammatory gene expression, whereas SO oil caused a
lower inflammatory response (fewer Cd11b-positive cells
and less Cd68, Tnf-a, or Ccl2 mRNA, P < 0.025 and P <
0.05, respectively) in female but not male mice.
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Figure 5 Presence and distribution of macrophages and neutrophils in the liver. Panels A and B: Cd68-positive macrophages in APOE2ki
mice on the low-fat OO diet without cholesterol (A) or on high-fat OO diet with cholesterol (B). Insets show high-power magnifications of
stained macrophages. Panels C and D: Cd11b-positive macrophages in a WT male liver (C; no macrophage activation) and a male APOE2ki liver
(D; grade-2 macrophage activation) on the high-fat olive oil diet. Macrophage activation based on the presence of Cd11b-positive cells in the
livers of animals of the respective experimental and control groups was graded on a scale of 0 to 3 (see additional file 2, table S2: Cd11b-scoring
criteria). The circle indentifies a cluster of activated macrophages. Panels E and F: Mpo-positive cells in livers assigned a grade 3 for Cd11b-
positive macrophages (E: without Mpo-positive cells; F: with Mpo-positive cells). Panel G: Median values of macrophage activation in each of the
groups are indicated by diamonds (male) and circles (female mice) (red: WT, blue: APOE2ki). The error bars represent the first and third quartiles
of each group. When not drawn, a quartile coincides with the median. Bars: 100 μm. Different letters indicate a significant difference (P < 0.05)
between the diets within male or female APOE2ki mice. GT: genotype; n.s.: non significant.
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Plasma cholesterol and inflammation
Further analysis of the APOE2ki livers showed that
Cd68, Tnf-a or Ccl2 mRNA expression were signifi-
cantly correlated (R2 = 0.73; P < 0.001; Figure 6D), indi-
cating that all these markers reflect the inflammatory
status of the liver. Further analysis revealed that plasma
cholesterol levels correlated with Cd68 and Tnf-a
mRNA expression in female mice (R2 = 0.29 and 0.49,
respectively), but were absent in male mice (R2<0.02;
Figure 6E and 6F). In addition, there was a stronger cor-
relation between plasma cholesterol and the degree of
the accumulation of Cd11b-positive cells in female mice
(R2 = 0.31; P = 0.001) than in male mice (R2 = 0.15; P =
0.013; additional file 7, figure S2: Correlation of liver
Cd11b scoring with plasma cholesterol levels).
Discussion
The experimental protocol of our study allowed a com-
parison of the effects of dietary fat saturation index in
two mouse models which differ in their susceptibility to
steatosis and steatohepatitis. C57BL/6J mice are widely
used in dietary fat studies, while APOE2ki mice on the
C57BL/6J background are a humanized mouse model
for hyperlipidemia. Surprisingly, the choice of fat plays
only a minor role in liver steatosis and inflammation.
Instead, cholesterol significantly modulates plasma and
liver values, while hepatic inflammation is also modified
by the female gender. Furthermore, we found evidence
that a relative deficiency of essential fatty acids may
affect hepatic fat metabolism. Finally, our findings show
a clear effect of gender, so female mice should be
included in further studies of NAFLD.
Saturation of the dietary fats does not affect steatosis
and liver inflammation
All fats were from plant sources. The fPF, which is used
in animal feed, would have been ideal to reveal the roles
of a high palmitate (~55%) content and a high degree of
saturation (~95%). Dietary palmitic acid is partly metabo-
lized to ceramides, which may cause inflammation [18].
A high-fat diet with only 30% of fPF (12% less than used
in this study) was reported to be tolerated by WT mice
[19]. Based on this report and the fact that FVB-mice
accepted the fPF-based diet, we conclude that fPF is not
toxic, but poorly tolerated by WT mice. Since high-fat
diets based on palm oil (~45% palmitate and ~50%
saturation) are well tolerated by WT mice [20], the melt-
ing point of the fat (fPF ~53°C versus CB ~35°C) rather
0
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Figure 6 Expression of inflammatory genes in livers of mice fed the respective high-fat diets. Cd68 mRNA expression is depicted in panel
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than the palmitic acid content appears to determine tol-
erance. Furthermore, cocoa butter, the diet with the high-
est palmitic acid (~24%) content and highest degree of
saturation (~65%) in this study, was also very well toler-
ated and even overconsumed by male WT males.
The degree of saturation of the dietary fat did not affect
steatosis or liver inflammation, which appears to contra-
dict the health claims for e.g. olive oil [21]. We used
refined grade oils and fats, so that the discrepancy may
be attributable to secondary compounds, like waxes and
polyphenols [22]. However, olive oil did also not amelio-
rate steatosis or liver inflammation in a long-term (12
weeks) high-fat diet study in rats [23]. Relative to other
fats, olive oil diminished steatosis in mice fed a methio-
nine-choline deficient (MCD) diet, but aggravated
inflammation [24]. These latter results have to be inter-
preted with care, though, since an MCD diet itself already
induces a disturbance of fatty-acid metabolism [24].
The discrepancy between the effects of olive oil (~72%
oleic acid content) and hoSO (~90% oleic acid) on liver
fat content of APOE2ki mice was unexpected. The
hoSO differs from all other dietary fats tested in its con-
tent of both saturated and polyunsaturated fatty acids
(<50% of that in the other diets). We suspect that espe-
cially the low dietary PUFA content (~5% versus 14% in
OO) may cause disturbances in lipid metabolism,
because feeding mice a diet deficient in 18:2 and 18:3
fatty acids for eight weeks causes hepatic steatosis [25].
If insufficient essential fatty acids are present in the diet,
oleic acid rather than linoleic or a-linolenic acid is elon-
gated and desaturated to form mead acid (20:3n-9) by
Δ6-desaturase [26]. In agreement with this hypothesis,
we found that hoSO-fed mice have a 1.6-fold increased
mead acid content in their livers. We believe that
APOE2ki mice were especially susceptible, because the
absolute influx of fat into the liver is lower than in WT
mice. Upregulation of lipogenesis in the hoSO-fed
APOE2ki mice is supported by the ~2-fold higher Fasn
and Srebf1 mRNA levels when compared to olive oil-fed
mice. However, palmitic and palmitoleic acid concentra-
tions, which must be synthesized de novo, since they are
not present in the hoSO diet, remained unchanged com-
pared to OO-fed mice.
The size of hepatic fat vesicles correlates with dietary fat
content and not with inflammation
If the majority of fat droplets that are visible in formal-
dehyde-fixed and paraffin-embedded sections is smaller
or bigger than the nucleus of a hepatocyte, this liver is
said to be micro- or macro-steatotic, respectively
[27,28]. Microvesicular steatosis corresponds with a
more serious inflammatory state [29]. Our finding is
that all high-fat diets increased the diameter of the fat
vesicles to a similar extent in WT and APOE2ki livers,
even though the fat content of APOE2ki livers was not
increased. This shows that the size distribution of fat
vesicles in cryosections stained with Oil-Red O reflects
dietary rather than hepatic fat content. These observa-
tions concur with human studies that nutritional fat
excess induces macrovesicular steatosis [30-32].
APOE2ki mice are protected against high-fat diet induced
steatosis
Liver fat accumulation in WT mice on a high-fat diet
was approximately twice that in APOE2ki mice, which,
with the exception of the hoSO diet, did not accumulate
extra fat. As in other hyperlipidemic mouse models
(Apoe-ko, Ldlr-ko), the high plasma cholesterol and tri-
glyceride levels reflect the reduced uptake of apolipopro-
tein particles into the liver. For that reason, these mouse
models are less likely to develop liver steatosis [33].
However, APOE2ki mice on a high-fat diet enriched in
short- and medium-chain fatty acids (<C14), such as
milk, do develop fatty livers [11], because these fatty
acids are not incorporated into chylomicrons [34].
Different dietary fats mainly accumulate as oleic acid in
the liver
An important finding of our study was that the composi-
tion of dietary fat has little influence on the chemical
composition of stored liver fat. Liver fat composition was
similar for all diets, with oleic acid as its main constitu-
ent. This finding demonstrates that liver fat composition
is determined by liver metabolism rather than dietary fat
composition. The conversion of liver fats to monounsatu-
rated fats by stearoyl-CoA desaturase (Scd-1) may avoid
accumulation of saturated fats, which results in inflam-
mation and apoptosis of hepatocytes [35]. Even sunflower
oil-fed mice preferentially stored monounsaturated trigly-
cerides, suggesting oxidation of PUFAs and recycling of
their carbons for de-novo fatty-acid synthesis [36,37].
Some of the linoleic acid and a-linolenic acid in the sun-
flower oil underwent further elongation and desaturation,
as can be deduced from increase n-3 (22:5n-3, 22:6n-3)
and n-6 (20:4n-6, 22:4n-6) fatty acid series in liver fat. In
agreement with previous studies these endogenously
synthesized PUFAs were not able to increase b-oxidation
via PPARa activation or suppress lipogenesis via Srebp1c
as observed with purified fish oil supplements (22:5n-3,
22:6n-3) [38].
Gender effect in NAFLD
Female APOE2ki mice showed a higher inflammatory
response than male APOE2ki mice which may be due to
differences in susceptibility of Kupffer cell activation
(see section on liver inflammation). Female mice are
more prone to develop endotoxin-induced inflammation
due to increased Tnf-a expression by Kupffer cells [39].
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Furthermore, female TLR4-/- mice have a more attenu-
ated inflammatory response upon a high-fat diet than
WT littermates. This effect was blunted in male mice,
indicating that females have a more sensitive TLR4-
mediated inflammatory response [40]. In female, as
opposed to male APOE2ki mice, plasma cholesterol cor-
related with inflammatory markers. Kupffer cells of
APOE2ki mice take up cholesterol from plasma [41].
Progesterone blocks the postlysosomal transport of cho-
lesterol in female mice [42,43]. As a consequence, cho-
lesterol can not be exported from the Kupffer cells and
inflammation is sustained. Female NASH-patients may,
therefore, benefit more from cholesterol-lowering treat-
ments than males.
We have shown that female mice, irrespective of gen-
otype, display consistently a lower inflammatory status
on the SO diet. With 25 en% of linoleic acid and only
0.2 en% of a-linolenic acid, SO has a much higher pro-
inflammatory linoleic acid (n-6) to anti-inflammatory a-
linolenic acid (n-3) ratio than the other diets. All SO-fed
mice (genotypes and genders) had a lower Δ5-desatura-
tion index of n-6 fatty acids (the ratio of 20:4(n-6) over
20:3(n-6) fats) in the liver than mice fed the other high-
fat diets. Female mice must, therefore, have a thus far
unknown, essential fatty-acid-independent mechanism
to decrease inflammation.
We report here that female WT mice on a low-fat diet
accumulate liver triglycerides to a same extent as on
high fat diets. PPARa is less active in female than in
male mice [44]. In addition, high carbohydrate levels in
the low-fat diet stimulate de-novo lipogenesis, as indi-
cated by the ~2 fold increased Srebf1 and ~5 fold
increase in Fasn expression (data not shown). This com-
bination can explain the higher liver triglyceride levels
in the low-fat diet. When cholesterol was omitted from
the low-fat diet, liver triglycerides in female WT mice
decreased significantly for an unknown reason that must
be linked to dietary cholesterol.
Factors contributing to liver inflammation
The number of Cd68-positive resident macrophages [45]
did not differ between diets and genotypes, but, as
observed previously [11,41], macrophages were more
swollen in the livers of APOE2ki mice fed a cholesterol-
containing diet than a diet without cholesterol. Appar-
ently, these macrophages take up excess cholesterol
from the hyperlipidemic plasma. The presence of
Cd11b-positive, newly recruited macrophages in liver
was higher in APOE2ki than in WT mice [45], but simi-
lar for all cholesterol-supplemented diets. The accumu-
lation of cholesterol in liver macrophages of APOE2ki
mice probably induces recruitment of activated macro-
phages. The significant correlation between plasma cho-
lesterol levels and the expression of the inflammatory
markers Cd11b, Cd68, and Tnf-a in liver supports this
reasoning, albeit that the contribution of plasma choles-
terol to the inflammatory state is most apparent in
female mice. This suggests that modulation of dietary
cholesterol might be especially beneficial for females.
Nevertheless, myeloperoxidase (Mpo)-positive cells were
recruited to the liver in 11% of all APOE2ki mice and,
specifically, to 25% of the livers with grade 3 of CD11b-
inflammation. Infiltration of Mpo-positive cells did not
correlate with a specific dietary fat. Since the infiltration
of Mpo-positive cells is a feature of human NASH
[46,47], APOE2ki mice are a promising animal model
for NASH. Liver triglyceride content did not correlate
with macrophage activation or neutrophil infiltration,
arguing against the accumulation of fat in hepatocytes
as the trigger of macrophage activation, as implied by
the two-hit hypothesis [2].
Conclusions
Our data emphasize the important role of dietary choles-
terol in the development of steatosis and steatohepatitis.
Dietary cholesterol regulates plasma cholesterol, trigly-
ceride, and NEFA concentrations. Plasma cholesterol, in
turn, correlates very tightly with liver inflammation in
female mice. Saturation of dietary fatty acids, on the
other hand, affects the severity of NAFLD only to a lim-
ited extent. We observed that oleic acid is the main fatty
acid component in liver, irrespective of the dietary fat
source. This study will serve as an excellent reference for
future studies on effects of macronutrients, since it cov-
ers the whole spectrum of fatty acid saturation. Further-
more, our findings demonstrate the necessity of gender-
specific research in the field of the metabolic syndrome.
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Additional file 1: Composition of control and high-fat diets. The
composition of the fatty acids of the different diets with respect to
saturation is represented in a table. Opens with Adobe Acrobat Reader.
Additional file 2: Cd11b-scoring criteria. The criteria for the scoring of
Cd11b-staining are shown. Opens with Adobe Acrobat Reader.
Additional file 3: Primer sequences for quantitative PCR. Sequences
of primers used for quantitative PCR. Opens with Adobe Acrobat Reader.
Additional file 4: Biometric details of experimental mice. Age, body
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Additional file 5: Energy intake and change in body weight of mice
fed the respective high-fat diets. The values present the average
energy intake (Panel A) and weight change (Panel B), respectively, per
mouse per day in the second and third week of the experimental diet.
Data are expressed as means ± SEM of 6-10 mice per group. Opens with
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cholesterol levels depicted in grey are the males, and in black are the
females. Opens with Adobe Acrobat Reader.
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